Status:
COMPLETED
The Effect of the Hemobag® Ultrafiltration System on Blood Conservation and Coagulation After Cardiopulmonary Bypass
Lead Sponsor:
MaineHealth
Collaborating Sponsors:
Global Blood Resources, LLC
Conditions:
Blood Coagulation Disorders
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This proposal is designed to mitigate hemodilution (blood diluted with an electrolyte solution) and loss of plasma proteins responsible for normal blood clotting as well as platelets at the completion...
Detailed Description
Background: Cardiopulmonary bypass (CPB) consists of an extracorporeal (outside of the body) circuit which allows the circulation and oxygenation of blood during cardiac surgery. The circuit includes...
Eligibility Criteria
Inclusion
- All adult cardiac surgery patients (age 18 or older) Cardiopulmonary bypass
Exclusion
- Patients under age 18 Off pump surgery
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01435304
Start Date
September 1 2011
End Date
December 1 2014
Last Update
June 6 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maine Medical Center
Portland, Maine, United States, 04102